Compare MYGN & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | MSGE |
|---|---|---|
| Founded | 1991 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 2.5B |
| IPO Year | 1996 | 2023 |
| Metric | MYGN | MSGE |
|---|---|---|
| Price | $4.59 | $57.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $7.64 | ★ $58.80 |
| AVG Volume (30 Days) | ★ 1.6M | 272.1K |
| Earning Date | 05-15-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.49 |
| Revenue | $771,400,000.00 | ★ $942,734,000.00 |
| Revenue This Year | $7.19 | $10.53 |
| Revenue Next Year | $5.64 | $6.53 |
| P/E Ratio | ★ N/A | $37.40 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.76 | $28.29 |
| 52 Week High | $10.30 | $65.26 |
| Indicator | MYGN | MSGE |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 43.14 |
| Support Level | $3.93 | $51.96 |
| Resistance Level | $5.63 | $64.18 |
| Average True Range (ATR) | 0.34 | 1.97 |
| MACD | 0.02 | -0.62 |
| Stochastic Oscillator | 16.43 | 26.51 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.